| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $63,199,145 ) (Continued on the next page) |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | K12ES033594 | Scholars in Environmental Pediatrics, Reproductive Health, and Life Course Science | 000 | 5 | NIH | 12/31/2025 | $481,564 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | K23MH136367 | Integrated Cognitive Rehabilitation and Cognitive Behavioral Therapy Intervention for patients with Post-COVID-19 Cognitive Impairment and Depression | 000 | 2 | NIH | 1/29/2026 | $194,381 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | K23DK127241 | Characterizing the Biologic Evolution of Crohn's Disease Like Pouch Inflammation in Ulcerative Colitis Patients After Restorative Proctocolectomy with Ileal Pouch Anal Anastomosis | 000 | 5 | NIH | 2/6/2026 | $190,904 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | K23DA062172 | ED-EXACT in Opioid Overdose: Emergency Department Evaluation of Xylazine-Associated Clinical Toxicity in Opioid Overdose | 000 | 1 | NIH | 2/11/2026 | $195,428 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01HL173593 | Cardiac AAV gene delivery for clinical translation | 000 | 3 | NIH | 2/16/2026 | $761,593 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01HL173456 | Microfluidic organoid model of cardio-hepatic physiology and disease | 000 | 3 | NIH | 2/16/2026 | $521,242 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01EB035491 | Engineering pluripotent stem cells to evade and promote immunity | 000 | 3 | NIH | 12/9/2025 | $477,398 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01ES032552 | The interplay of early life exposure to environmental pollutants and folate system in the etiology of autistic behaviors | 000 | 5 | NIH | 12/30/2025 | $582,537 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01ES034864 | Cardiometabolic diseases in the World Trade Center general responder cohort and the role of subsequent environmental exposures | 000 | 4 | NIH | 1/21/2026 | $474,332 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01ES035791 | Prenatal and infant household air pollution exposure, the human microbiome and virome, and childhood lung function: the GRAPHS randomized controlled trial | 001 | 2 | NIH | 1/29/2026 | $118,029 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01ES035791 | Prenatal and infant household air pollution exposure, the human microbiome and virome, and childhood lung function: the GRAPHS randomized controlled trial | 000 | 2 | NIH | 1/27/2026 | $1,231,131 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01ES035773 | Early-life environmental exposure mixtures and biological age acceleration in children and adolescents: susceptibility, potential interactions and underlying mechanisms | 001 | 3 | NIH | 1/19/2026 | $69,858 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01ES035773 | Early-life environmental exposure mixtures and biological age acceleration in children and adolescents: susceptibility, potential interactions and underlying mechanisms | 000 | 3 | NIH | 1/13/2026 | $518,142 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01HD092990 | Extracellular regulation of Xenopus development | 000 | 7 | NIH | 1/21/2026 | $475,118 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DC020980 | Mechanisms of anosmia and brain infection in a genetic mouse model of COVID-19 | 001 | 3 | NIH | 2/11/2026 | $70,391 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DC020980 | Mechanisms of anosmia and brain infection in a genetic mouse model of COVID-19 | 000 | 3 | NIH | 12/2/2025 | $633,533 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DK134773 | Genetic Analysis of Intrinsic Sensory Neuron Function in the Enteric Neural Circuits | 000 | 4 | NIH | 1/29/2026 | $598,796 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DK129735 | Podocyte-specific Rap1 agonism for treatment of glomerular disease | 000 | 5 | NIH | 1/30/2026 | $618,264 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DK131525 | Elucidating the Molecular Mechanisms that Mediate DKD Progression in Patients Living with HIV | 000 | 5 | NIH | 12/23/2025 | $841,127 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DK124133 | Uncovering the rules of gut microbiome strain transmission | 000 | 7 | NIH | 1/8/2026 | $617,193 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DK112978 | The Influence Of Gut Microbiota Stability In Inflammatory Bowel Disease | 000 | 8 | NIH | 2/16/2026 | $641,450 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DK064640 | Transcription factors in kidney development | 000 | 21 | NIH | 12/18/2025 | $688,041 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DK118222 | Mechanosensitive determinants of podocyte physiology | 000 | 7 | NIH | 1/8/2026 | $725,168 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DK139395 | Genetic risk and molecular characterization of Diabetic Kidney Disease | 000 | 3 | NIH | 1/21/2026 | $331,100 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DK141891 | Manufacture of defined live microbial therapeutics for infectious and inflammatory disease | 000 | 2 | NIH | 1/19/2026 | $671,511 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DK137968 | The effects of a high fructose diet on the gut microbiome and metabolic health: A controlled clinical intervention study | 000 | 3 | NIH | 12/22/2025 | $729,507 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DK139631 | Nrf2 and the expansion and preservation of beta cell mass | 000 | 3 | NIH | 2/16/2026 | $735,808 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DK146762 | EYA1 as a novel regulator of HIV-induced end stage kidney disease | 000 | 1 | NIH | 2/13/2026 | $683,660 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DK138025 | microRNA-controlled mRNA therapeutics | 000 | 3 | NIH | 1/16/2026 | $559,205 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DK136016 | Hepatic stellate cell plasticity and maladaptive fibrogenic memory in chronic liver disease | 000 | 4 | NIH | 2/9/2026 | $592,181 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DK136035 | Interleukin-10 mediated immune cell-adipocyte crosstalk in adipose thermogenesis | 000 | 3 | NIH | 1/16/2026 | $618,621 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01MH104559 | ROLE OF PERIPHERAL IMMUNE-DERIVED MMP8 IN STRESS SUSCEPTIBILITY | 000 | 13 | NIH | 12/9/2025 | $842,950 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01MH116900 | Molecular studies of neural histone monoaminylation in normal and aberrant brain plasticity | 000 | 8 | NIH | 12/22/2025 | $844,899 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01CA269954 | HLA-E and NKG2A define a novel immune checkpoint axis in non-muscle-invasive bladder cancer | 000 | 4 | NIH | 1/27/2026 | $600,457 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01CA301057 | Dissecting the hematopoietic pathways governing age-associated pathogenic myelopoiesis | 000 | 2 | NIH | 1/26/2026 | $612,301 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01DA008863 | Regulation Of Opioid Receptor Signaling by Endogenous Peptides | 001 | 31 | NIH | 2/6/2026 | $58,833 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | U01AG073148 | A Humanized Monoclonal FSH Blocking Antibody for Alzheimer's Disease | 001 | 5 | NIH | 2/2/2026 | $2,321,095 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | U01AG073148 | A Humanized Monoclonal FSH Blocking Antibody for Alzheimer's Disease | 001 | 5 | NIH | 2/2/2026 | -$2,321,095 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R35GM144117 | Construction of in vivo mRNA delivery systems | 000 | 6 | NIH | 1/16/2026 | $418,275 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R37CA269982 | Promoting immunity against acute myeloid leukemia through Fc effector-optimized antibody inhibitory of MICA/B shedding | 000 | 4 | NIH | 12/8/2025 | $468,806 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R37CA246239 | Potentiating Checkpoint Blockade by Cross-Priming Tumor-Reactive T cells with In Situ Vaccination | 000 | 7 | NIH | 1/29/2026 | $316,731 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R37CA269982 | Promoting immunity against acute myeloid leukemia through Fc effector-optimized antibody inhibitory of MICA/B shedding | 001 | 4 | NIH | 1/20/2026 | $0 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R24ES036917 | GeoSpace - GeoSpatial Knowledgebase for Exposomics | 000 | 2 | NIH | 2/13/2026 | $591,500 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R35GM127289 | Cyclin-dependent kinase control of cell-division and transcription cycles | 000 | 9 | NIH | 1/30/2026 | $456,300 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R35GM137905 | Mapping the Dynamic Interactome of Ig-fold Membrane Proteins Using Nanobody-Based Tools | 001 | 6 | NIH | 2/13/2026 | $462,000 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R21AI187731 | CRISPR-Cas9 base editing approaches to discover ubiquitination events promoting flavivirus infection | 000 | 2 | NIH | 12/1/2025 | $211,250 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R21EY037046 | Reconstruction of a human blood-retina barrier and perfused vascular system to investigate the role of APOE variants in age-related macular degeneration | 000 | 2 | NIH | 2/3/2026 | $211,250 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01NS106229 | Harnessing YAP-TEAD Activity as Anti-Invasion Therapeutic in Human Glioblastoma | 000 | 7 | NIH | 1/9/2026 | $581,154 |
| | 2026 | 2026 | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI | 1 GUSTAVE L LEVY PL | NEW YORK | NY | 10029-6504 | NEW YORK | USA | R01NS135728 | Investigating the Neurobiology of Early Cognitive Impairment | 000 | 3 | NIH | 1/14/2026 | $552,728 |
|
